Results for this period
Interim period (second quarter)1 October 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In the medical and nursing care cloud platform business, revenue increased due to the acquisition of new customers, strong performance in website development, internet advertising and personnel-matching services, and customized development for major customers. In the healthy life expectancy extension business, growth in the number of users at existing stores and reductions in store operating costs contributed to results. In the solutions development business, costs preceded revenue recognition on some projects.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025–31 March 2026 |
| Net Sales | ¥3,134 million (YoY +17.8%) |
| Operating profit | ¥1,000 million (YoY +30.9%) |
| Ordinary income | ¥1,009 million (YoY +32.1%) |
| Profit attributable to owners of the parent | ¥670 million (YoY +29.3%) |
| Net income per share | ¥14.12 |
| Equity ratio | End of the current fiscal period 71.5 / End of previous period 71.1 |
| Total assets | ¥7,009 million |
| Net assets | ¥5,010 million |
| Cash flows from operating activities | ¥820,843 thousand |
| Cash flows from investing activities | ¥-235,593 thousand |
| Cash flows from financing activities | ¥-515,616 thousand |
| Cash and cash equivalents at end of period | ¥3,419,429 thousand |
| Full-year earnings forecast | Net Sales ¥6,350 million (YoY +15.4%) / Operating profit ¥2,050 million (YoY +27.5%) / Ordinary income ¥2,050 million (YoY +27.1%) / Profit attributable to owners of the parent ¥1,370 million (YoY +23.2%) |
| Revision to Earnings Forecast | No (unchanged) |
| Annual Dividend Forecast | ¥7.5 → ¥9（+20.0%） |
| Segment revenue | Medical and Nursing Care Cloud Platform Business ¥2,083,195 thousand (YoY +17.0%), Healthy Life Expectancy Extension Business ¥713,518 thousand (YoY +29.6%), Solutions Development Business ¥338,009 thousand (YoY +2.4%) |
| Segment profit | Medical and Nursing Care Cloud Platform Business ¥949,991 thousand (YoY +28.9%), Healthy Life Expectancy Extension Business ¥111,198 thousand (YoY +94.1%), Solutions Development Business ¥-16,337 thousand |
| Depreciation and amortization | ¥167,848 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Added: 0 companies (names: —); removed: 0 companies (names: —) |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person For securities analysts and institutional investors |
| Issued Shares at Period-End | 48,132,000 Shares |
| Treasury Shares at Period-End | 674,706 Shares |
| Factors Behind Changes in Business Performance | In the medical and nursing care cloud platform business, revenue increased due to the acquisition of new customers, strong performance in website development, internet advertising and personnel-matching services, and customized development for major customers. In the healthy life expectancy extension business, growth in the number of users at existing stores and reductions in store operating costs contributed to results. In the solutions development business, costs preceded revenue recognition on some projects. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the medical and nursing care cloud platform business, revenue benefited from the continued acquisition of new customers, strong performance in website development for major nursing care operators, internet advertising and personnel-matching services, and customized development for major customers. In the healthy life expectancy extension business, the number of users at existing stores increased, while reductions in store operating costs, including through the digital transformation of store operations, also supported profit. The solutions development business reported a segment loss because costs preceded revenue recognition on some projects.